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C E L L  B I O L O G Y
The unconventional biogenesis of  
Kv7.1-KCNE1 complexes
Anna Oliveras1*, Clara Serrano-Novillo1*, Cristina Moreno2, Alicia de la Cruz3, 
Carmen Valenzuela3,4, Christian Soeller5, Núria Comes6, Antonio Felipe1†
The potassium channel Kv7.1 associates with the KCNE1 regulatory subunit to trigger cardiac IKs currents. Although 
the Kv7.1/KCNE1 complex has received much attention, the subcellular compartment hosting the assembly is the 
subject of ongoing debate. Evidence suggests that the complex forms either earlier in the endoplasmic reticulum 
or directly at the plasma membrane. Kv7.1 and KCNE1 mutations, responsible for long QT syndromes, impair asso-
ciation and traffic, thereby altering IKs currents. We found that Kv7.1 and KCNE1 do not assemble in the first stages 
of their biogenesis. Data support an unconventional secretory pathway for Kv7.1-KCNE1 that bypasses Golgi. This 
route targets channels to endoplasmic reticulum–plasma membrane junctions, where Kv7.1-KCNE1 assemble. 
This mechanism helps to resolve the ongoing controversy about the subcellular compartment hosting the associ-
ation. Our results also provide new insights into IKs channel localization at endoplasmic reticulum–plasma membrane 
junctions, highlighting an alternative anterograde trafficking mechanism for oligomeric ion channels.
INTRODUCTION
The voltage-gated potassium type 7.1 (Kv7.1) channel is the first of 
five members of the Kv7 subfamily and is included in the Kv super-
family (1). Although Kv7.1 is widely distributed throughout the hu-
man body, it plays a major role in cardiac tissue (2). In the heart, 
Kv7.1 associates with the regulatory  subunit KCNE1, giving rise 
to the slow delayed rectifier potassium (IKs) current, which is vital 
for proper repolarization of cardiac action potentials (3, 4). Cardiac 
channelopathies are responsible for about half of sudden cardiac 
death cases, and their current worldwide prevalence ranges from 
1:2000 to 1:3000 in the general population. The most prevalent dis-
order within this group is congenital long QT syndrome. Among 
the 17 different types identified within this disease, Kv7.1 is associ-
ated with more than 30% of the described genetic variants, clearly 
underscoring its physiological importance (5).
Although Kv7.1-KCNE1 complexes are some of the most studied 
molecules in the ion channel field, many biological features are still 
elusive. For instance, the precise mechanism of the slow activation 
induced by KCNE1 (6), the stoichiometry of the complex (7), and 
the subcellular location where Kv7.1-KCNE1 complexes assemble 
are subjects of intense debate. Concerning this last issue, opposing 
evidence strongly supports two different hypotheses: (i) Kv7.1 and 
KCNE1 traffic separately to the plasma membrane (PM), and dy-
namic complexes are assembled directly at the cell surface (3, 8–10) 
or (ii) the association takes place early during the secretory pathway 
(11–17). The anterograde journey of Kv7.1 and KCNE1 subunits 
from the sites of their biosynthesis to the PM starts at the endoplasmic 
reticulum (ER). Next, the subunits should follow the classic secretory 
pathway, including exit from the ER and travel through the ER-to-
Golgi intermediate compartment, the Golgi apparatus, and the 
trans-Golgi network (TGN) (18, 19). However, recent evidence sug-
gests that some membrane proteins, including some ion channels, 
can reach the PM unconventionally (20–23). Deciphering Kv7.1- and 
KCNE1-specific secretory pathways may help to uncover the precise 
subcellular compartment for Kv7.1-KCNE1 complex assembly, eluci-
dating to the pathological mechanisms of deficient Kv7.1-KCNE1 asso-
ciation and trafficking observed in many cardiac channelopathies (6).
Cardiomyocytes exhibit organized structures that facilitate exci-
tation-contraction coupling. T-tubules are narrow invaginations of 
the sarcolemma facing adjacent sarcoplasmic reticulum that couple 
ion channel–mediated electrical activity with the release of calcium 
from intracellular stores, triggering contraction. T-tubules are the 
best-characterized ER-PM junctions. ER-PM junctions are ubiqui-
tous cellular structures that play crucial roles not only in Ca2+ sig-
naling but also in membrane trafficking (24, 25). Some cardiac Kv 
channels, including Kv7.1, are localized in these subcellular domains, 
but the targeting mechanism is still poorly understood (26) .
In the present study, we investigated Kv7.1 and KCNE1 secretory 
pathways. Unlike KCNE1, Kv7.1 is unconventionally routed to the 
cell surface, bypassing the Golgi. Upon association, Kv7.1 rerouted 
KCNE1 from classic anterograde transport. This route drives Kv7.1 
and KCNE1 to ER-PM junctions, where the complexes assemble. 
This previously unidentified mechanism for Kv7.1-KCNE1 complex 
trafficking and assembly contributes to resolving the ongoing 
controversy about the subcellular compartment where the interaction 
takes place. We also provide new evidence for the local generation 
of the IKs current within ER-PM junctions at T-tubules.
RESULTS
Kv7.1/KCNE1 association recapitulates IKs currents 
and forms stable complexes at cardiac T-tubules
Cardiac IKs currents are crucial for heart physiology, but many ques-
tions remain regarding the localization and formation of functional 
Kv7.1/KCNE1 complexes. Therefore, we first investigated the colo-
calization and interaction of the subunits in rat cardiomyocytes. 
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We used direct stochastic optical reconstruction microscopy (dSTORM) 
to locate Kv7.1 and KCNE1 in cardiomyocytes (Fig. 1). Fluorophore- 
coupled antibodies stained ryanodine receptor (RyR), which identified 
ER-PM junction structures where Kv7.1 localized (Fig. 1, A to C). 
Although Kv7.1 and KCNE1 showed notable whole-cell colocaliza-
tion (Fig. 1, D to F), a detailed analysis demonstrated that colocal-
ization was higher in T-tubules and PM than in other cell areas 
(Fig. 1, G and H). A distance of 0 nm determined by dSTORM sug-
gests physical association (27). Coimmunoprecipitation of both 
proteins in protein extracts from rat hearts further confirmed this 
association (Fig. 1I). Reverse coimmunoprecipitation confirmed 
the interaction. Our data indicated that Kv7.1 and KCNE1 asso-
ciate in the T-tubules of rat cardiomyocytes. This association 
recapitulated IKs currents when the subunits were steadily expressed 
in human embryonic kidney–293 (HEK-293) cells (Fig. 1, J and K). 
Heterologous expression of Kv7.1–cyan fluorescent protein (CFP) 
and KCNE1–yellow fluorescent protein (YFP) highlighted further 
subcellular localization features (Fig. 1, L to P). While KCNE1 was 
mostly present at the cell surface, Kv7.1 exhibited notable intracel-
lular retention. As previously demonstrated in cardiomyocytes (28), 
the colocalization of both proteins was threefold higher at the PM 
than the rest of the cell (Fig. 1P), resembling the distribution within 
T-tubules in the heart.
Kv7.1-KCNE1 complexes are assembled at the PM
Compared to entire cells, cell unroofing preparations (CUPs) enable 
better discrimination between cell surface and intracellular com-
partments (fig. S1). CUPs were obtained through hypotonic shock 
plus an intense burst (fig. S1, E to H; see Materials and Methods for 
details). Alternatively, by applying gentle rather than intense bursts, 
we obtained modified CUPs (mCUPs), in which part of the ER 
compartment remained attached to the PM through ER-PM junc-
tions (fig. S1, I to L). Thus, by using a membrane-localized CFP-YFP 
tandem construct (Rho-pYC) and ER-DsRed, an ER marker, we 
discriminated between the cellular compartments (fig. S1M).
The colocalization between Kv7.1 and KCNE1 at the PM was 
higher in CUPs (89 ± 1%) than in entire cells (64 ± 1%;Fig. 2, A to G). 
Physical interaction was assessed by Förster resonance energy transfer 
(FRET) analysis and protein coimmunoprecipitation. Kv7.1-CFP/
Kv7.1-YFP and Kv7.1-CFP/Kv1.5-YFP were used as positive and 
negative controls, respectively (29). Kv7.1-YFP and KCNE1-CFP 
showed a FRET efficiency comparable to that of the negative con-
trol in entire cell preparations (0.04 ± 0.02 and 0.03 ± 0.00 for 
Kv7.1-KCNE1 and Kv7.1-Kv1.5, respectively). In contrast, Kv7.1 
and KCNE1 showed significant positive energy transfer efficiency (EF) 
in CUPs (0.15 ± 0.01%, P < 0.001 versus entire cell) (Fig. 2, H to R). 
Coimmunoprecipitation assays further supported the FRET results. 
Stronger coimmunoprecipitation of Kv7.1 and KCNE1 was detected 
in PM-enriched protein samples purified from CUPs than in sam-
ples from whole cells (Fig. 2, S and T). Reverse coimmunoprecipita-
tion confirmed the interaction. Therefore, while the Kv7.1-KCNE1 
complex is detected in entire cells, the interaction is mostly localized 
at the PM.
Kv7.1-KCNE1 complexes are not assembled in  
early biogenesis
The ongoing debate about the subcellular location of Kv7.1-KCNE1 
complex assembly has raised two possible alternative mechanisms: 
(i) Kv7.1 and KCNE1 traffic independently to the PM, where they 
form transient complexes by lateral diffusion (3, 8–10), and (ii) the 
assembly takes place in the ER, and the interaction is required for 
the efficient trafficking of KCNE1 to the PM (11–17). In this con-
text, we analyzed the subcellular compartment hosting Kv7.1- 
KCNE1 association. We first studied Kv7.1 and KCNE1 colocalization 
with ER and PM markers (Fig. 3 and fig. S2). Both Kv7.1 and 
KCNE1, when expressed alone, were highly retained in the ER. 
However, upon coexpression of Kv7.1, KCNE1 targeting to the PM 
significantly increased with a concomitant reduction in ER reten-
tion. The Kv7.1 distribution remained unaltered (Fig. 3, A to G, and 
fig. S2, Aa to Ac, Ea to Ec, and Ia to Id). Biotin assays further sup-
ported that KCNE1 expression at the PM increased when KCNE1 
was coexpressed with Kv7.1 (Fig. 3, H and I). As expected, HEK-293 
and COS-7 cells showed similar expression patterns (fig. S3, A to K). 
These results indicated that association with Kv7.1 promoted KCNE1 
trafficking to the cell surface and suggested that the Kv7.1-KCNE1 
interaction might take place within the secretory pathway.
We next measured the interaction between Kv7.1 and KCNE1 either 
at the PM or in the ER compartment by using mCUPs (Fig. 3, J to S). 
The FRET efficiency between Kv7.1 and KCNE1 at the ER was low 
(0.05 ± 0.01), similar to that of Kv7.1 tetramers (0.07 ± 0.01), but 
was higher than that of the negative Kv7.1-Kv1.5 control (0.03 ± 0.01, 
P < 0.01). Within the same cell, positive FRET values suggested a 
physical interaction of Kv7.1 and KCNE1 at the PM (0.14 ± 0.02, 
P < 0.001 versus the ER). These findings indicated that Kv7.1 and 
KCNE1 assembled in a post-ER compartment rather than early in 
their biogenesis. Similar results were obtained in COS-7 cells (fig. 
S3, L to U).
Kv7.1-KCNE1 complexes traffic through an unconventional 
secretory pathway
To identify the intracellular compartment where Kv7.1 and KCNE1 
interact, the Kv7.1 and KCNE1 post-ER secretory pathway to the 
cell surface (Fig. 4 and fig. S2) was examined. KCNE1 followed the 
classic secretory pathway, colocalizing with a cis-Golgi marker 
(GM130, 34 ± 6%), a TGN marker (TGN46, 20 ± 2%), and an early 
endosome marker (EEA1, 24 ± 2%; Fig. 4, A to C and J). However, 
Kv7.1 colocalization was rather low (GM130, 4 ± 1%; TGN46, 
7 ± 1%; and EEA1, 4 ± 1%) (Fig. 4, D to F and J). The absence of 
Kv7.1 from Golgi compartments suggested that this protein traffics 
to the PM through a pathway bypassing this organelle. Upon 
KCNE1 coexpression, the Kv7.1 pattern was mainly unaltered, 
whereas KCNE1 distribution was changed (Fig. 4, G to J). Thus, 
KCNE1, when coexpressed with Kv7.1, mistargeted the cis-Golgi 
network, TGN, and early endosomes, mimicking the unconventional 
Kv7.1 behavior. Similar results were obtained by electron microscopy. 
While KCNE1, in the absence of Kv7.1, was detected in Golgi com-
partments (Fig 4K), Kv7.1, in the absence of KCNE1, mainly stained 
ER structures (Fig. 4L). Upon Kv7.1-KCNE1 coexpression, KCNE1 
relocated in the ER (Fig. 4M). No changes in Kv7.1 ER patterns were 
observed either in the presence or absence of KCNE1 (Fig. 4, L and M). 
Collectively, these observations not only suggest that Kv7.1 traffics 
via an unconventional secretory pathway but also demonstrate that 
the Kv7.1-KCNE1 association shifts KCNE1 from its classic route 
to the cell surface.
To further decipher the Kv7.1-KCNE1 noncanonical secretory 
pathway, we used a dominant-negative mutant of Sar1 guanosine 
triphosphatase (GTPase; Sar1H79G) and brefeldin A (BFA; Fig. 5 
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Fig. 1. Kv7.1 and KCNE1 recapitulate cardiac IKs currents and associate in T-tubules in cardiomyocytes. (A to H) dSTORM in rat ventricular cardiomyocytes. 
Fluorophore- coupled antibodies were used to stain native proteins. (A) Staining for RyR in cardiac T-tubules. (B) Kv7.1 (red) and (C) merge image. (D to F) Staining for Kv7.1 
and KCNE1 in cardiac T-tubules. (D) Kv7.1, red; (E) KCNE1, green; (F) colocalization of Kv7.1 and KCNE1, yellow. Scale bars, 5 m. (G) Magnified area from the square in (F). 
The insets delineate the representative regions of interest analyzed in (H). (H) Kv7.1-KCNE1 colocalization at a 0-nm distance determined by dSTORM analysis. Color code 
in (G) and (H): gray, PM; white, T-tubules; blue, nontubule area excluding the previous structures. The black bar represents whole-cell colocalization. Statistical analysis 
determined a P < 0.001 by analysis of variance (ANOVA) with a Tukey post hoc test. **P < 0.01 and ***P < 0.001 (insets, n > 10 from five independent cells). (I) Kv7.1 coim-
munoprecipitates with KCNE1 in rat cardiac samples. Total crude protein extracts from rat ventricular cardiomyocytes were immunoprecipitated (IP) with anti-Kv7.1 antibodies 
and immunoblotted (IB) against Kv7.1 (left) and KCNE1 (right). SM, starting material; SN, supernatant; +AB, presence of antibodies; −AB, absence of antibodies during the 
immunoprecipitation. (J) Coexpression of Kv7.1 and KCNE1 in COS-7 cells recapitulates IKs currents. COS-7 cells were cotransfected with Kv7.1 and KCNE1 for 24 and 48 hours. 
The cells were held at −40 mV, and 5.5-s depolarizing pulses was applied from −80 to +60 mV. (K) Maximal intensity of currents at +60 mV. White bar, cells transfected for 
24 hours; black bar, currents recorded after 48 hours of expression. The values are the means ± SEM of six to eight cells. **P < 0.01 versus 24 hours, Student’s t test. (L to P) 
Expression of Kv7.1 and KCNE1 in HEK-293 cells. Cells were cotransfected with Kv7.1-CFP and KCNE1-YFP for 48 hours, and representative confocal images were acquired. 
(L) Kv7.1, red; (M) KCNE1, green; (N) PM marker, blue; (O) merged signals. White represents triple colocalization. Scale bar, 10 m. (P) Cellular colocalization of Kv7.1-CFP 
and KCNE1-YFP. The PM staining was used to create a mask to analyze the Kv7.1-KCNE1 colocalization. Whole cell, the entire cell was analyzed. Without (W/O) PM, whole-
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(COPII)–mediated ER exit (30). BFA inhibits ER-to-Golgi traffick-
ing (31). Both factors, impairing the communication between the 
ER and the Golgi, disrupt the Golgi apparatus (fig. S4, Ba, Ca, Ea, 
Fa, Ha, and Ia) (32). Blockade of ER-to-Golgi transport increased 
KCNE1 ER retention [control (68 ± 3%) versus Sar1H79G (94 ± 1%) 
and BFA (95 ± 2%), P < 0.001] (Fig. 5, A to C and J). The ER clusters 
of KCNE1 overlapped the Sar1H79G distribution (figs. S4B and 
S5B). This finding confirmed that KCNE1 is recruited as cargo by 
COPII vesicles at ER exit sites. In contrast, the ER localization of 
Kv7.1 did not change under Sar1H79G coexpression or BFA treat-
ment (control, 73 ± 2%; Sar1H79G, 77 ± 3%; and BFA, 71 ± 3%) 
(Fig. 5, D to F and J). When Kv7.1 and KCNE1 were coexpressed, no 
treatment affected the ER localization of either subunit (Fig. 5, G to J). 
Coimmunoprecipitation confirmed that Kv7.1 and KCNE1 still 
associated after the canonical secretory pathway was disrupted, fur-
ther supporting the hypothesis that association with Kv7.1 mediates 
KCNE1 redistribution (Fig. 5, K and L). Redirecting KCNE1 to a 
nonconventional pathway bypassing the Golgi could trigger changes 
in the glycosylation of the regulatory subunit. Therefore, we next 
analyzed the glycosylation pattern of Kv7.1 and KCNE1, in the presence 
or absence of Kv7.1, using tunicamycin as a general N-glycosylation 
inhibitor and a cocktail of glycosidases to identify complex N- and 
O-glycosylation. Unlike Kv7.1, the association of KCNE1 with Kv7.1 
triggered a partial loss of larger KCNE1 bands (>50 kDa), compati-
ble with a reduction in the glycosylation of the protein similar to 
that observed in the presence of either tunicamycin or the glycosi-
dase (Gase) cocktail (Fig. 5, M and N).
Kv7.1 and KCNE1 assemble in ER-PM junctions
Kv7.1-KCNE1 reached the PM after interacting in a post-ER com-
partment and bypassing the Golgi apparatus. Similarly, the neuro-
nal channel Kv2.1, which localizes in ER-PM junctions (24), resides 
at the tips of ER projections that extend close to the PM (Fig. 6, Aa 
to Ae). In our study, Kv7.1 and KCNE1 were highly colocalized at 
discrete sites in peripheral regions of the ER (Fig. 6, Ba to Be). We 
performed three-dimensional (3D) image reconstruction of the cell 
volume and surface rendering to analyze the structures (fig. S6 and 
movie S1). Kv2.1 was located in projections of the ER compartment, 
Fig. 2. Kv7.1 and KCNE1 mostly interact at the PM. (A to F) Confocal images of KCNE1-YFP and Kv7.1-CFP in entire cells (A to C) and CUPs (D to F). Cells were cotrans-
fected with KCNE1-YFP (A and D, in green) and Kv7.1-CFP (B and E, in red). (C and F) Merged image showing colocalization in yellow. (G) Colocalization analysis by 
Manders’ (M) coefficient in entire cells (black bar) or CUPs (white bar). The values show the means ± SEM. ***P < 0.001 CUP versus entire cell (n = 9 to 15, Student’s t test). 
(H to Q) Representative results of FRET acceptor photobleaching experiments on entire cells (H to L) and CUPs (M to Q). The prebleaching images (H to I and M and N) 
show the expression of KCNE1-YFP (H and M) and Kv7.1-CFP (I and N). After bleaching the acceptor molecule (KCNE1-YFP), postbleaching images were taken (J and K and 
O and P). The bleached area is highlighted with a white square. (L and Q) FRET ratio images from the previous panels. The calibration bar indicates the FRET ratio ranging 
from 0.8 (blue) to 1.4 (red). Scale bars, 10 m. (R) Energy transfer efficiencies. The values represent the means ± SEM of the FRET measured in entire cells (black) or in CUPs 
(white). ***P < 0.001 CUP versus entire cell (n = 31 to 36, Student’s t test). (S) Coimmunoprecipitation of Kv7.1 with KCNE1 using anti-KCNE1 antibodies (IP: KCNE1) in CUPs 
and whole-cell lysates entire cells (EC; entire cells) from cultured cells. Immunoblotting was performed with antibodies against Kv7.1 (IB: Kv7.1, 100 kDa, arrow) and KCNE1 
(IB: KCNE1, 37 kDa, arrow). −, immunoprecipitation in absence of anti-KCNE1 antibodies. (T) Coimmunoprecipitation (co-IP) analysis of Kv7.1 with KCNE1 in entire cells 
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in close contact with the PM (Fig. 6, Ca to Cf). Surface rendering of 
Kv7.1-KCNE1 showed completely overlapping distributions in similar 
structures (Fig. 6, Da to Df, and movie S2). This ER-PM junction 
distribution was further confirmed in a 3D reconstruction video with 
multiple labeling of Kv7.1, KCNE1, the PM, and the ER (movie S3).
Last, we wanted to determine whether Kv7.1 and KCNE1 colo-
calize at ER-PM junctions and assemble into complexes. Electron 
micrographs demonstrated that while Kv7.1, which was absent 
from the Golgi (fig. S7D), localized in ER structures and ER-PM 
junctions (fig. S7A), KCNE1, which was located in the Golgi appa-
ratus (fig. S7E), was absent from these sites (fig. S7B). However, 
upon association with Kv7.1, KCNE1 mostly disappeared from the 
Golgi and stained ER-PM structures (fig. S7, C and F). Furthermore, 
FRET measurements in ER-PM junctions from mCUPs demonstrated 
Fig. 3. Kv7.1-KCNE1 assembly within the secretory pathway. (A to F) Representative images of KCNE1-YFP (A, green), Kv7.1-CFP (B, red), and KCNE1-YFP + Kv7.1-CFP 
(C, green and red) coexpressed with Akt-PH-pDsRed (A to C, PM marker in blue) and ER-DsRed (D to F, blue) in HEK-293 cells. PH, pleckstrin homology. (A and D) Cyan 
shows colocalization between green and blue. (B and E) Magenta shows colocalization between red and blue. (C and F) Yellow shows partial colocalization between green 
and red. White shows triple colocalization between green, red, and blue. Scale bar, 10 m. (G) M coefficient analysis of KCNE1 (black), Kv7.1 (white), and Kv7.1 + KCNE1 
(light and dark gray) overlapping the ER and membrane (PM) markers. The bars represent the means ± SEM. **P < 0.01 and ***P < 0.001 for KCNE1 in the absence of Kv7.1 
versus KCNE1 in the presence of Kv7.1 (n = 19 to 40, Student’s t test). (H) Biotin assay of KCNE1 and Kv7.1 cell surface expression. HEK-293 cells were transfected with Kv7.1-CFP, 
KCNE1-YFP, and Kv7.1-CFP + KCNE1-YFP. After transfection, the cells were labeled with biotin and processed as described in Materials and Methods. Western blot analysis 
was performed with anti-Kv7.1 (IB: Kv7.1) and anti-KCNE1 (IB: KCNE1) antibodies. Biotin, biotinylated pull down proteins. (I) Densitometric analysis of biotinylated Kv7.1 
and KCNE1. KCNE1 (black), Kv7.1 (white), and Kv7.1 + KCNE1 (light and dark gray, respectively). The bars represent the means ± SEM. ***P < 0.001 for KCNE1 in the absence 
of Kv7.1 versus KCNE1 in the presence of Kv7.1 (n = 3, Student’s t test). (J to R) Representative results of Kv7.1-CFP and KCNE1-YFP FRET experiments in ER-containing CUPs 
(mCUPs). (J to L) Prebleaching images of KCNE1-YFP (J), Kv7.1-CFP (K), and ER-DsRed (L). (M and N) Postbleaching images of KCNE1-YFP (M) and Kv7.1-CFP (N). The 
bleached area is highlighted with a white square. (O) Merged prebleaching image (J to L). (Q) Magnified view of the bleached area in the merged image that enables the 
PM to be distinguished from the ER. (P and R) FRET ratio images. The calibration bar ranges from 0.8 (blue) to 1.4 (red). Scale bar, 10 m. (S) FRET was measured inde-
pendently in the PM (black bars) and the ER (white bars) within the same cell. The values indicate the means ± SEM. ***P < 0.001 for Kv7.1-KCNE1 in the PM versus the ER 
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that Kv7.1 and KCNE1 were associated in these structures (fig. S7, 
Ea to G). We detected highly variable FRET efficiency between 
Kv7.1 and KCNE1 within ER-PM junctions (Fig. 6F). While 42% of 
the ER-PM junctions exhibited very low FRET values (ER-PM−, 
0.01 ± 0.01), 58% showed FRET efficiencies significantly higher than 
those of perinuclear ER regions [ER-PM+, (0.14 ± 0.01) versus ER 
(0.05 ± 0.01), P < 0.001) and similar to those of the PM (0.17 ± 0.01; 
Fig. 6G). This variability in FRET efficiencies revealed two different 
populations of ER-PM junctions: (i) FRET-negative structures in 
which association was either low or absent and (ii) FRET-positive 
ER-PM junctions in which interaction between Kv7.1 and KCNE1 
had occurred. These data suggest that ER-PMs are specific sites 
where ongoing Kv7.1-KCNE1 complex assembly takes place.
DISCUSSION
In the present study, we found that Kv7.1 and KCNE1 use different 
secretory pathways to target the PM. While KCNE1 is driven through 
the Golgi from the ER using COPII-dependent anterograde transport, 
Kv7.1 uses an alternative COPII-independent mechanism, bypassing 
the Golgi apparatus. However, Kv7.1-KCNE1 association shifts KCNE1 
from the conventional secretory pathway. This nonconventional 
trafficking route targets both subunits to ER-PM junctions in which 
Kv7.1-KCNE1 complexes oligomerize before reaching the cell sur-
face. Previous evidence has indicated the existence of opposing 
mechanisms, suggesting that Kv7.1-KCNE1 complexes are formed 
either in the ER compartment or at the PM (3, 8–17) . In this con-
text, our results contribute to resolving this debate. Kv7.1 associates 
with KCNE1 at ER-PM junctions, which is entirely compatible with 
the locations of these channels in cardiac T-tubules. Therefore, our 
data pave the way for resolving an ongoing controversy in cardiac 
physiology and elucidate an emerging unconventional mechanism 
for ion channel PM delivery.
Most newly synthesized proteins exit ER trafficking through the 
Golgi to reach the cell surface. However, some ion channels reach the 
PM unconventionally by using COPII-independent mechanisms 
and/or bypassing the Golgi. The molecular mechanisms of this 
noncanonical secretion pathway are still poorly understood. While 
Kv4.2 bypasses COPII vesicles when it is associated with Kv channel- 
interacting protein (KChIP) (21, 22), cystic fibrosis transmembrane 
conductance regulator uses both COPII-dependent and -independent 
routes and bypasses the Golgi under ER stress conditions (23). 
Fig. 4. Kv7.1 and KCNE1 colocalization with post-ER compartments of the secretory pathway. (A to C) KCNE1 colocalization with post-ER subcellular compartment 
markers. (A) Cis-Golgi network (GM130), (B) TGN (TGN46), and (C) early endosomes (EEA1). Green, KCNE1-YFP; blue, subcellular compartments; cyan, colocalization be-
tween green and blue. (D to F) Kv7.1 colocalization with GM130 (D), TGN46 (E), and EEA1 (F). Red, Kv7.1-CFP; blue, subcellular compartments; magenta, colocalization 
between red and blue. (G to I) Kv7.1 + KCNE1 colocalization with GM130 (G), TGN46 (H), and EEA1 (I). KCNE1-YFP localization is shown in green, Kv7.1-CFP is shown in red, 
and the corresponding subcellular compartments are shown in blue. White shows triple colocalization between green, red, and blue. Yellow shows partial green and red 
colocalization. Scale bars, 10 m. (J) The values represent the means ± SEM of the M overlap coefficient between KCNE1 (black), Kv7.1 (white), or Kv7.1 + KCNE1 (light and 
dark gray) and the corresponding subcellular compartment. *P < 0.05, **P < 0.01, and ***P < 0.001 (n = 10 to 34, Student’s t test). (K to M) Electron micrographs of KCNE1 
(K), Kv7.1 (L), and Kv7.1 + KCNE1 (M) in HEK-293 cells. (K) KCNE1 staining of Golgi cisternae as indicated by the black arrowheads. Representative ER structures are circled. 
(L) Kv7.1 was located in ER-like structures, indicated by the white arrowheads, and was absent from the vicinity of the Golgi. (M) KCNE1 (indicated by the black arrow-
heads) disappeared from the Golgi cisternae and was located in ER-like structures in the presence of Kv7.1 (indicated by the white arrowheads). Kv7.1, 12-nm gold parti-
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Fig. 5. Kv7.1 and Kv7.1-KCNE1 complexes follow an unconventional secretory pathway. (A to I) Images of KCNE1-YFP (green, A to C), Kv7.1CFP (red, D to F), and 
Kv7.1-CFP + KCNE1-YFP complexes (red and green, G to I) colocalizing with ER-DsRed (blue) in the absence (A, D, and G) or the presence of either Sar1H79G (B, E, and H) 
or BFA (C, F, and I). Cyan, colocalization between KCNE1-YFP (green) and ER-DsRe (blue); magenta, colocalization between Kv7.1-CFP (red) and blue; and white, triple 
colocalization of green, red, and blue. (G to I) Partial colocalization between KCNE1 (green) and Kv7.1 (red) is also shown in yellow. Scale bars, 10 m. (J) M coefficient 
values for the overlap of KCNE1 (black), Kv7.1 (white), and Kv7.1 + KCNE1 (light and dark gray) with ER marker in the absence (control) or the presence of either Sar1H79G 
or BFA. The values represent the means ± SEM. ***P < 0.001 for the ER overlap of KCNE1 in the presence of Sar1H79G and BFA versus that of KCNE1 under control conditions 
(n = 7 to 19, Student’s t test). (K) Coimmunoprecipitation of Kv7.1 with KCNE1 using anti-Kv7.1 antibodies (IP: Kv7.1) in whole-cell lysates from HEK-293 cells cotransfected 
with Kv7.1-CFP and KCNE1-YFP in the absence (C) or the presence of Sar1H79G. Immunoblotting was performed against Kv7.1 (IB: Kv7.1) and KCNE1 (IB: KCNE1). (L) Co-
immunoprecipitation of Kv7.1 with KCNE1 using anti-KCNE1 antibodies (IP: KCNE1) in whole-cell lysates from HEK-293 cells cotransfected with Kv7.1-CFP and KCNE1-YFP 
and treated without (C) or with BFA. Immunoblotting was performed against Kv7.1 (IB: Kv7.1) and KCNE1 (IB: KCNE1). −, immunoprecipitation in the absence of antibodies. 
(M) Analysis of KCNE1 glycosylation in the presence of tunicamycin. HEK-293 cells were transfected with KCNE1-YFP and Kv7.1-CFP + KCNE1-YFP and treated (+) or not 
treated (−) with tunicamycin (5 g/ml). Cell extracts were immunoprecipitated and immunoblotted with anti-Kv7.1 and anti-KCNE1 antibodies. (N) Analysis of KCNE1 
glycosylation in the presence of a cocktail of glycosidases (Gase). HEK-293 cells were transfected with KCNE1-YFP and Kv7.1-CFP + KCNE1-YFP and treated with EndoH, 
peptide N-glycosidase F (PNGase F), and PNGase 1 to PNGase 4 galactosidase (Gase). Cell extracts from Kv7.1-CFP + KCNE1-YFP–transfected HEK-293 cells were immu-
noprecipitated with anti-Kv7.1 antibodies and immunoblotted with anti-Kv7.1 and anti-KCNE1 antibodies. Cell extracts from HEK-293 cells transfected with KCNE1 were 
immunoprecipitated with anti-KCNE1 antibodies and 50 g of immunoprecipitate treated with Gase and immunoblotted with anti-Kv7.1 and anti-KCNE1 antibodies. Note 
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Here, we show that Kv7.1 reaches the PM through an unconven-
tional secretory pathway. Several lines of evidence support this 
argument: (i) the absence of colocalization at post-ER subcellular 
compartments, (ii) ER exit via a COPII-independent mechanism, 
and (iii) surface expression after Golgi disruption.
The identity of the secretory compartment hosting Kv7.1-KCNE1 
assembly is one of the most controversial topics regarding cardiac 
IKs currents (3–5). Evidence supports two opposing hypotheses: (i) 
Kv7.1 and KCNE1 traffic separately to the cell surface, where they 
form dynamic complexes with up to four KCNE1 subunits per complex 
Fig. 6. ER-PM junctions are platforms for Kv7.1-KCNE1 complex assembly. HEK-293 cells were transfected with Kv2.1-YFP and Kv7.1-CFP + KCNE1-YFP and with 
ER-DsRed and Akt-PH-pDsRed as ER and PM markers, respectively. (Aa to Ae) Kv2.1 colocalization with the ER compartment. (Aa) Merged image of Kv2.1-YFP (green) and 
ER-DsRed (blue) staining. Cyan, colocalization. (Ab) ER-DsRed. (Ac) Mask of the subcellular distribution of the Kv2.1-ER colocalization signal. (Ad) Merge image of Aa and 
Ac. (Ae) Magnified view [white rectangle in (Ad)]. (Ba to Be) Kv7.1 and KCNE1 subunits colocalize at discrete sites in distal ER domains. (Ba) Kv7.1-CFP (red) and KCNE1-YFP 
(green) coexpression. Yellow, colocalization. (Bb) ER-DsRed expression is shown in blue. (Bc) Mask of the subcellular distribution of the Kv7.1-KCNE1 colocalization signal. 
(Bd) Merge of the images in Bb and Bc. (Be) Magnified view [white rectangle in (Bd)]. Kv7.1-KCNE1 colocalized with the ER marker (white) in discrete areas juxtaposed with 
the PM. Scale bars, 10 m. (Ca to Cf) Kv2.1 localization at ER-PM junctions in 3D surface renders. (Ca to Cd) Maximal projection of the z stack of the whole-cell volume. (Ca) 
Kv2.1-YFP, green; (Cb) PM, red; (Cc) ER, blue; (Cd) Merged image. Scale bars, 10 m. The white rectangle indicates the magnified area in (Ce) and (Cf). White, triple colocal-
ization. The arrows indicate Kv2.1 at ER-PM junctions. (Cf) 3D surface render. ER, blue; PM, red; Kv2.1, green. The white arrow points to an ER-PM contact site where Kv2.1 
is localized. Scale bar, 1.5 m. (Da to Df) Kv7.1-KCNE1 complexes localized at ER-PM junctions in 3D surface renders. (Da to Dd) Maximal projection of the z stack of the 
whole-cell volume. (Da) Kv7.1-CFP, red; (Db) KCNE1-YFP, green; (Dc) ER, blue; (Dd) merge. Scale bars, 10 m. The white rectangle indicates the magnified area in (De) and 
(Df). (De) White, triple colocalization. The arrows highlight Kv7.1-KCNE1 at ER-PM junctions. (Df) 3D surface render. ER, blue; Kv7.1, red; KCNE1, green. The white arrow 
points to a Kv7.1-KCNE1 complex localized at a cortical ER projection juxtaposed with the PM. Scale bar, 2 m. (Ea to Ei) Results of FRET experiments between Kv7.1-CFP 
and KCNE1-YFP in mCUPs. (Ea and Eb) Prebleaching images showing KCNE1-YFP in green (Ea) and Kv7.1-CFP in red (Eb). (Ec and Ed) Postbleaching images of KCNE1-YFP 
(Ec) and Kv7.1-CFP (Ed). The bleached area is highlighted with a white square. (Ee) ER-DsRed, blue. (Ef) Merged image of (Ea) to (Ee). (Eh) Magnified view of the bleached 
area in the merged image that enables the PM (green line) to be distinguished from the ER (red line). Kv7.1 and KCNE1 were highly colocalized in discrete ER-related 
structures identified as ER-PM junctions (yellow line). (Eg and Ei) Original and magnified FRET ratio images, respectively. The calibration bars range from 0.8 (blue) to 
1.4 (red). Scale bar, 10 m. (F) Plot of individual FRET measurements in the PM (black), ER-PM junctions (gray), and the ER (white) in mCUPs. (G) FRET measurements in the 
PM (black), positive ER-PM junctions (+, dark gray), negative ER-PM junctions (−, light gray), and the ER (white) within the same cell. The bars represent the means ± SEM 
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(11–17) or (ii) Kv7.1-KCNE1 channels assemble early at the ER 
with a fixed 4:2 stoichiometry and travel together toward the PM 
(3, 8–10). The second hypothesis implies that KCNEs reside in the 
ER until they coassemble with Kv isoforms. The interaction medi-
ates the progression of the complex through the secretory pathway 
(13). However, we and others have found that KCNE1 targets the 
PM in different situations: (i) when it is expressed alone (33), (ii) 
when the interaction with the  subunit is compromised (17, 34), 
and (iii) when PM-residing Kv7.1-KCNE1 complexes are saturated 
(10). Moreover, we found that KCNE1 follows the classic COPII- 
dependent secretory pathway and that Kv7.1-KCNE1 association 
occurs within the secretory pathway rather than at the PM. In this 
study, (i) targeting of KCNE1 to the PM was enhanced upon Kv7.1 
coexpression. (ii) The presence of Kv7.1 reduced KCNE1 localiza-
tion at post-ER secretory compartments. (iii) Kv7.1 rerouted KCNE1 
to the nonconventional secretory pathway.
These results raise other important implications that need fur-
ther debate. First, both subunits do not traffic independently to the 
PM to form reversible and transient complexes. The robust FRET 
efficiency detected between Kv7.1 and KCNE1 at the PM supports 
the formation of stable protein complexes rather than reversible 
and transient interactions. However, we cannot dismiss the possi-
bility that additional freely diffusing KCNE1 monomers at the PM 
could interact with nonsaturated complexes bearing less than four 
 subunits (10). Second, evidence suggests that a single KCNE1 
peptide may interact with a Kv7.1 dimer during the biogenesis of 
Kv7.1 tetramers. The subsequent dimerization of dimers would 
generate an oligomeric complex with a fixed stoichiometry of 4:2 
(Kv7.1:KCNE1) (7). However, our data indicate that Kv7.1-KCNE1 
assembles after Kv7.1 tetramerization. The results obtained with 
our FRET-positive control, Kv7.1-CFP/Kv7.1-YFP, suggested the 
existence of homotetramers of Kv7.1 in the overall ER compartment. 
However, Kv7.1 and KCNE1 interaction was only detected at discrete 
sites at the very tips of ER tubules and cisterns.
We visualized Kv7.1-KCNE1 in ER-PM membrane contact sites 
in patterns resembling Kv2.1 localization at ER-PM junctions. 
Kv2.1 plays a major role in regulating neuronal action potential fre-
quency (35), but it is also a major component of IKs currents in 
rodent hearts, sharing a functional role with Kv7.1-KCNE1 in hu-
man cardiomyocytes (36). Moreover, KCNE1 can also form native 
cardiac complexes with Kv2.1 (37). In cardiomyocytes, Kv7.1 and 
Kv2.1, as well as other Kv channels, such as Kv4.2 and Kv11.1, are 
localized in T-tubules, which are specialized cardiac ER-PM junc-
tions (26, 38). The short intermembrane cleft allows rapid commu-
nication between the PM and ER compartments, maximizing 
contraction strength and reducing response time. T-tubules are 
diffusion-restricted domains, and this accumulation of K+ channels 
probably leads to high K+ concentrations within the extracellular 
lumen. Kv7.1-KCNE1 complexes are resistant to the inactivation 
that high extracellular K+ produces on Kv7.1 homotetramers (39). 
In addition, ER-PM junctions are crucial in Ca2+ signaling and 
excitation-contraction coupling in myocytes. Kv7.1-KCNE1 complexes 
are regulated by Ca2+ at many different levels, such as the levels of 
assembly, trafficking, and function (14, 40). FRET studies on ER-PM 
junctions revealed that most of these structures contained perfectly 
assembled Kv7.1-KCNE1 complexes. However, some of the ER-PM 
junctions showed negative FRET efficiencies. This variability sug-
gests that ER-PM junctions are specific platforms for the ongoing 
assembly of Kv7.1-KCNE1 complexes. ER-PM junctions not only 
participate in Ca2+ signaling but also function as PM protein traf-
ficking hubs (24, 25). Kv7.1 and KCNE1 may traffic independently 
to ER-PM junctions, structures that accommodate the assembly of 
the complexes before delivery to the cell surface. Kv7.1-KCNE1 
complex assembly and trafficking at/through ER-PM junctions may 
represent efficient mechanisms for localized subcellular regulation 
of IKs currents.
In conclusion, we have demonstrated that Kv7.1-KCNE1 com-
plexes are not assembled in early biogenesis. Kv7.1 reroutes KCNE1 to 
a nonconventional secretory pathway through ER-PM junctions. The 
complexes are assembled at these sites and subsequently delivered 
to the PM. Because IKs currents are essential for cardiac repolarization, 
the implications of our study might be crucial for understanding many 
heart pathologies.
MATERIALS AND METHODS
Plasmids, cell culture, and transfection
Human Kv7.1 complementary DNA (cDNA) in a pTLN vector was pro-
vided by T. Jentsch (Leibniz-Institut für Molekulare Pharmakologie 
and Max-Delbrück-Centrum für Molekulare Medizin, Germany). 
Human KCNE1 cDNA in a pHA vector was obtained from S. de la 
Luna (Centro de Regulación Genómica, Spain). Rat YFP-Kv2.1HA 
was obtained from M. Tamkun (Colorado State University, USA). 
For confocal microscopy and molecular biology studies, the Kv7.1, 
KCNE1, and Kv1.5 cDNA sequences were cloned into pECFP-N1/
pEYFP-N1, pEYFP-N1, and pEYFP-C1 vectors (Clontech), respec-
tively. The constructs were verified by sequencing. The PDsRed-tagged 
pleckstrin homology (PH) domain of Akt (Akt-PH-pDsRed), used as 
a membrane marker, was a gift from F. Viana (Universidad Miguel 
Hernández, Spain). An ER marker (pDsRed-ER), a soluble CFP 
(pECFP-N1), and a soluble YFP (pEYFP-N1) were obtained from 
Clontech. Membrane-localized Rho-pYC, which consists of the 
C-terminal prenylation site of Rho (RQKKRRGCLLL) appended to 
the C terminus of the YFP-CFP fusion protein, was donated by 
F. Barros and P. de la Peña (Universidad de Oviedo, Spain). 
Hemagglutinin (HA)–Sar1H79G was provided by R. Pepperkok 
(European Molecular Biology Laboratory, Germany).
HEK-293 and COS-7 cells were grown in Dulbecco’s modified 
Eagle’s medium supplemented with 10% (v/v) fetal bovine serum 
and penicillin/streptomycin (100 U/ml). For molecular biology 
experiments, cells were plated in 100-mm culture dishes. For confo-
cal microscopy studies, cells were plated on poly-d-lysine–coated 
coverslips. Transient transfection was performed using Lipotrans-
fectine (AttendBio Research) when the cells had reached nearly 80% 
confluence. In some experiments, the cells were treated with BFA 
(Sigma-Aldrich) at 5 g/ml for 4 hours to ensure the complete turn-
over of Kv7.1 and Kv7.1-KCNE1 complexes.
CUPs and immunocytochemistry
CUPs are membrane sheets obtained through osmotic shock (41). 
HEK-293 cells were seeded on poly-d-lysine–treated glass coverslips. 
Forty-eight hours after transfection, the cells were cooled on ice for 
5 min and washed twice in phosphate-buffered saline (PBS). Next, 
the cells were incubated for 5 min in KHMgE buffer [70 mM KCl, 
30 mM Hepes, 5 mM MgCl2, and 3 mM EGTA (pH 7.5)], diluted 
threefold, and then gently washed with undiluted KHMgE to induce 
hypotonic shock. Lysed cells were removed from the coverslips by 
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buffer, only the membrane sheets remained attached. We also used 
a milder modified protocol based on a gentler burst to prepare 
mCUPs. In mCUPs, a fraction of the ER compartment remains 
connected to the PM by the ER-PM junctions (fig. S1). The prepa-
rations were fixed with fresh 4% paraformaldehyde (PFA) in PBS 
for 10 min at room temperature and mounted with homemade 
Mowiol mounting medium.
To detect the cis-Golgi network (GM130), the TGN (TGN46), 
the early endosomes (EEA1), and the ER (calnexin), we performed 
immunocytochemistry. After fixation, cells were further permeabi-
lized with 0.1% Triton X-100 for 20 min. After 1 hour of incubation 
with blocking solution (10% goat serum, 5% nonfat powdered milk, 
and 0.05% Triton X-100), the cells were incubated with the follow-
ing primary antibodies in 10% goat serum and 0.05% Triton X-100 
overnight at 4°C: mouse anti-GM130 (1:1000; BD Transduction 
Laboratories), rabbit anti-TGN46 2F11 (1:100; bioNova científica), 
mouse anti-EEA1 (1:500; BD Transduction Laboratories), and mouse 
anti-calnexin (1:100; BD Transduction Laboratories). Next, the cells 
were incubated with either goat anti-rabbit or mouse Cy5-conjugated 
secondary antibodies for 2 hours at room temperature and further 
mounted with homemade Mowiol mounting medium.
Confocal microscopy and FRET experiments
Cell preparations were imaged under a Leica SP2 laser scanning 
confocal spectral microscope (Leica Microsystems GmbH) equipped 
with an argon multiline laser (458, 488, and 514 nm), a diode-pumped 
solid-state laser (561 nm), and a helium-neon laser (633 nm). Images 
of the YFP fluorophore were obtained using the 514-nm laser line, 
those of CFP were obtained using the 458-nm line, those of DsRed 
were obtained using the 561-nm line, and those of Cy5 were ob-
tained using the 633-nm line. Double dichroic (458/514) and triple 
dichroic (488/568/633) filters were used accordingly. Images were 
acquired at a resolution of 1024 × 1024 pixels using a 63× oil 
immersion objective lens (numerical aperture, 1.32) and scanning 
with a pinhole aperture of 1 Airy unit at zoom 4 following the 
Nyquist theorem to achieve maximal lateral optical resolution. 
Scanning was performed sequentially for observation of each fluo-
rescent protein.
Colocalization analysis was carried out using Manders’ (M) 
coefficient based on global analysis of pixel intensity distributions. 
The coefficient varies from 0 to 1, the former corresponding to non-
overlapping images and the latter reflecting 100% colocalization 
between both images [Just Another Colocalization Plugin (JACoP); 
https://imagej.nih.gov/ij/plugins/track/ jacop.html]. When colocalization 
between Kv7.1 and KCNE1 was assessed, the M coefficient reflected the 
proportion of Kv7.1 signal coincident with KCNE1 signal. Alternatively, 
we estimated the colocalization between either Kv7.1 or KCNE1 and 
specific subcellular markers. In that case, the M coefficient showed 
the overlapping distribution of a given subunit (Kv7.1 or KCNE1) 
with the evaluated subcellular compartment.
We measured FRET by the acceptor photobleaching method. 
Three scans of the region of interest (ROI) using the 514-nm line of 
an argon laser at 100% power intensity were performed. Before and 
after photobleaching, CFP and YFP images were collected. All im-
ages were sampled at 512 × 512 pixels with a 12-bit resolution. FRET 
EF was calculated following the formula EF = (Dpost − Dpre)/Dpost, 
where D is the CFP fluorescence intensity before (Dpre) or after 
(Dpost) photobleaching normalized by the CFP fluorescence intensity 
outside the ROI to monitor CFP photobleaching due to imaging. 
Alternatively, qualitative FRET ratio images are presented in some 
figures. Analysis was performed using ImageJ.
For 3D reconstructions, we obtained z-stack images of whole-
cell volumes. Acquisitions were performed following the Nyquist 
theorem in the x, y, and z axes. Next, the confocal images were 
deconvoluted using Huygens Essential software (Scientific Volume 
Imaging B.V.) to compensate for the optical distortion during 
acquisition. Using Imaris software (Bitplane), we reconstructed the 
optical sections into a 3D representation. The volume data from the 
3D reconstructions were rendered to represent the anatomical sur-
faces of the particular objects of interest. This information is shown 
in the figures as surface renders.
Superresolution imaging
Hearts were freshly obtained from wild-type male Wistar rats 
according to a protocol approved by the Animal Ethics Approval 
Committee of the University of Exeter (UK). The whole hearts were rinsed, 
and the ventricles were selectively dissected and frozen in optimal cutting 
temperature compound (O.C.T.) (Tissue-Tek). Frozen sections (10 m 
thick) were cut using a Leica CM3050 cryostat and collected onto 
precleaned coverslips coated with 0.1% poly-l-lysine (Sigma). The 
sections were blocked using an Image-iT FX signal enhancer (Thermo 
Fisher Scientific) for 1 hour at room temperature (RT). Primary 
antibodies against Kv7.1 (Santa Cruz Biotechnology), KCNE1 (Alomone), 
and RyR2 (Thermo Scientific) were applied overnight at 4°C. Next, the 
samples were incubated for 2 hours at RT with secondary antibodies 
conjugated to Alexa Fluor 647 or Alexa Fluor 700 (Thermo Fisher 
Scientific). Imaging was performed in switching buffer (90% glycerol 
and 100 mM 2-mercaptoethylamine in PBS). For image acquisition, 
dSTORM images were obtained with a modified Ti Eclipse inverted 
fluorescence microscope (Nikon, Japan). Image processing, event 
localization, and grayscale rendering were performed using custom- 
written PYthon Microscopy Environment software (https://bitbucket.
org/david_baddeley/python-microscopy). Colocalization analysis was 
performed as previously described (27).
Immunoprecipitation, biotinylation, and Western blotting
Hearts were freshly obtained from wild-type male Wistar rats ac-
cording to a protocol approved by the Animal Ethics Approval 
Committee of the University of Exeter. The hearts were digested 
with collagenase and homogenized until cell dissociation, and the 
homogenates were then centrifuged for 1 min at 750 rpm. Lysis 
buffer [150 mM NaCl, 50 mM tris, 1 mM EDTA, 1 mM EGTA, 1 mM 
MgCl2, and 1% Triton X-100 (pH 7.2)] was added, and the samples 
were mixed, incubated for 20 min until complete disaggregation at 
4°C, and centrifuged at 12,000g for 10 min at 4°C. The supernatants 
were kept as protein extract and prepared for Western blot analysis 
and immunoprecipitation.
Immunoprecipitation experiments on transfected HEK-293 cells 
were performed 48 hours after transfection. The cells were washed 
twice with ice-cold PBS and lysed in 1% Triton X-100, 10% glycerol, 
5 mM Hepes (pH 7.2), and 150 mM NaCl supplemented with 
aprotinin (1 g/ml), leupeptin (1 g/ml), pepstatin (1 g/ml), and 1 mM 
phenylmethylsulfonyl fluoride as protease inhibitors to isolate total 
protein samples. To purify proteins in CUPs, before lysis, the CUP pro-
tocol was performed in transfected HEK-293 cells cultured in 100-mm 
dishes. The homogenates were centrifuged at 12,000g for 15 min, 
and the total protein content of each supernatant was determined 









Oliveras et al., Sci. Adv. 2020; 6 : eaay4472     1 April 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
11 of 12
(GE Healthcare) were incubated with anti-KCNE1 or anti-Kv7.1 
antibodies (Alomone) for 1 hour at RT. Once bead-antibody com-
plexes were formed, they were covalently bound with dimethyl 
pimelimidate (DMP) (Pierce). The bead-antibody complexes were 
incubated with 20 mM DMP for 30 min at RT. The cross-linking 
reaction was quenched by adding 0.2 M glycine (pH 2.5). The cell 
lysates were precleared with protein A–Sepharose beads for 1 hour 
at 4°C. Equal amounts of protein samples were incubated overnight 
with the bead-antibody complexes at 4°C. After five washes, the 
proteins bound to the antibody-bead complexes were eluted in 100 l 
of 0.2 M glycine (pH 2.5).
Cell surface protein biotinylation was carried out with the Pierce 
Cell Surface Protein Isolation Kit (Pierce). Briefly, cells were incu-
bated with EZ-Link Sulfo-NHS-SS-Biotin (sulfosuccinimidyl-2- 
[biotinamido]ethyl-1,3-dithiopropionate) for 30 min, and surplus-free 
reagent was then quenched following the manufacturer’s instructions. 
Lysates, processed as above, were incubated overnight at 4°C in 
NeutrAvidin Agarose columns. After three washes, the biotinylated 
surface proteins were eluted in a dithiothreitol SDS–polyacrylamide 
gel electrophoresis (SDS-PAGE) sample buffer.
For Western blotting, protein samples were prepared in 1× Laemmli 
SDS loading buffer, incubated for 10 min at 65°C, and resolved by 
8 to 10% SDS-PAGE. The proteins were transferred to Immobilon-P 
nitrocellulose membranes (Millipore), which were blocked in 5% 
powdered milk in PBS with 0.05% Tween-20 before immunodetec-
tion. The membranes were immunoblotted with antibodies against 
Kv7.1 (anti-Kv7.1; 1:500) and KCNE1 (anti-KCNE1; 1:500), both 
from Alomone. After washing, the blots were incubated with horse-
radish peroxidase (HRP)–conjugated goat anti-rabbit secondary 
antibodies (Bio-Rad) and developed using the Chemiluminescence 
Detection Kit for HRP (Biological Industries).
Transmission electron microscopy
HEK-293 cells were transfected with Kv7.1CFP, KCNE1YFP, or 
Kv7.1pCDNA3.1 + KCNE1YFP and cultured for 48 hours before 
being fixed with PFA and glutaraldehyde at RT. The proteins were 
labeled using polyclonal anti-Kv7.1 antibodies (1:500; Alomone) 
and monoclonal anti-GFP mouse antibodies (1:50; Neuromab) for 
KCNE1YFP. Goat anti-rabbit and goat anti-mouse secondary anti-
bodies conjugated to 12-nm and 18-nm gold particles, respectively, 
were used to recognize Kv7.1CFP and KCNE1YFP. Briefly, samples 
were fixed for 1 hour with 4% PFA and 0.1% glutaraldehyde in 
0.1 M PBS and then in 2% PFA for 30 min. High-pressure freezing 
cryofixation with liquid N2 and cryosubstitution, Lowicryl resin 
embedding, polymerization of blocks, and ultrathin sectioning at a 
60-nm thickness were performed in collaboration with the Unitat de 
Criomicroscòpia Electrònica (CCiT, Universitat de Barcelona). The 
samples were mounted over Formvar-coated grids, and the sections 
were lastly contrasted with 2% uranyl acetate for 15 min and 
immunogold-labeled as abovementioned. The samples were observed 
using a Tecnai Spirit 120 kV microscope.
Glycosylation studies
Tunicamycin inhibits N-glycosylation. Cells treated with tunicamycin 
(5 g/ml; Sigma-Aldrich) were washed twice with PBS, lysed, and 
processed for Western blot analysis. Furthermore, a sequential 
deglycosylation protocol to remove all N-linked and many common 
O-linked glycans from glycoproteins was also used. Transfected 
HEK cells were lysed as described above, and Kv7.1 and KCNE1 
were immunoprecipitated. Sequential enzymatic reactions for 1 hour 
at 37°C followed by heat inactivation were performed following the 
manufacturer’s instructions (New England Biolabs). Briefly, 50 g 
of immunoprecipitates was sequentially treated for EndoH, peptide 
N-glycosidase F (PNGase F), and PNGase 1 to PNGase 4 galacto-
sidase digestion. Control samples were incubated with reaction 
buffers in the absence of glycosidases. Last, the samples were sub-
jected to SDS-PAGE for Western blot analysis.
Electrophysiology
Currents were recorded from COS-7 cells using the perforated 
(amphotericin B) patch-clamp technique with an Axopatch 200B 
amplifier (Axon Instruments), as previously described (41). The 
intracellular pipette filling solution contained 80 mM K-aspartate, 
50 mM KCl, 3 mM phosphocreatine, 10 mM KH2PO4, 3 mM 
Mg–adenosine 5′-triphosphate, 10 mM Hepes-K, and 5 mM EGTA 
and was adjusted to pH 7.25 with KOH. The bath solution con-
tained 130 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 
10 mM Hepes-Na, and 10 glucose and was adjusted to pH 7.40 with 
NaOH. Amphotericin B (20 mM; Sigma-Aldrich) was prepared in 
dimethyl sulfoxide and added to the internal solution to a final con-
centration of 0.5 mg/ml, as reported (41).
The currents were filtered at 1 kHz (with a four-pole Bessel filter) 
and sampled at 2 kHz. Micropipettes were pulled from borosilicate 
glass capillary tubes (Narishige, GD-1) on a programmable hori-
zontal puller (Sutter Instruments Co.) and heat-polished with a 
microforge (Narishige). The micropipette resistance was 1 to 3 M. 
pClamp version 9 software (Axon Instruments) was used for data 
acquisition and analysis. The currents were recorded at RT (21° to 
23°C) at a stimulation frequency of 0.03 Hz. The Microcal Origin 
2018 (Microcal Software) and Clampfit 10.8 programs were used to 
perform least squares fitting and for data presentation.
Statistics
The data are shown as the means ± SEM. Statistical analysis was 
performed by Student’s t test and one-way analysis of variance 
(ANOVA) with a post hoc test.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/14/eaay4472/DC1
View/request a protocol for this paper from Bio-protocol.
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